235 related articles for article (PubMed ID: 36371172)
1. Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021.
Lyimo E; Fougeroux C; Malabeja A; Mbwana J; Hayuma PM; Liheluka E; Turner L; Gesase S; Lavstsen T; Lusingu JPA; Minja DTR; Wang CW
BMC Infect Dis; 2022 Nov; 22(1):846. PubMed ID: 36371172
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
4. High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey.
Nyawale HA; Moremi N; Mohamed M; Njwalila J; Silago V; Krone M; Konje ET; Mirambo MM; Mshana SE
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141938
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes.
Lusingu JP; Jensen AT; Vestergaard LS; Minja DT; Dalgaard MB; Gesase S; Mmbando BP; Kitua AY; Lemnge MM; Cavanagh D; Hviid L; Theander TG
Infect Immun; 2006 May; 74(5):2867-75. PubMed ID: 16622225
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of asymptomatic malaria, submicroscopic parasitaemia and anaemia in Korogwe District, north-eastern Tanzania.
Hayuma PM; Wang CW; Liheluka E; Baraka V; Madebe RA; Minja DTR; Misinzo G; Alifrangis M; Lusingu JPA
Malar J; 2021 Oct; 20(1):424. PubMed ID: 34715886
[TBL] [Abstract][Full Text] [Related]
9. Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure.
Kessler A; Campo JJ; Harawa V; Mandala WL; Rogerson SJ; Mowrey WB; Seydel KB; Kim K
Malar J; 2018 Apr; 17(1):178. PubMed ID: 29695240
[TBL] [Abstract][Full Text] [Related]
10. Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progressively declining transmission.
Ishengoma DS; Mmbando BP; Mandara CI; Chiduo MG; Francis F; Timiza W; Msemo H; Kijazi A; Lemnge MM; Malecela MN; Snow RW; Alifrangis M; Bygbjerg IC
Malar J; 2018 Jul; 17(1):252. PubMed ID: 29976204
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania.
Peprah S; Dhudha H; Ally H; Masalu N; Kawira E; Chao CN; Genga IO; Mumia M; Were PA; Kinyera T; Otim I; Legason ID; Biggar RJ; Bhatia K; Goedert JJ; Pfeiffer RM; Mbulaiteye SM
Trop Med Int Health; 2019 May; 24(5):571-585. PubMed ID: 30843638
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.
Levorson RE; Christian E; Hunter B; Sayal J; Sun J; Bruce SA; Garofalo S; Southerland M; Ho S; Levy S; Defillipi C; Peake L; Place FC; Hourigan SK
PLoS One; 2021; 16(11):e0259823. PubMed ID: 34748615
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic.
Schonfeld D; Fernández H; Ramírez J; Acosta D; Becerra J; Wettstein M; Strella T; Vaccaro M; Arias S; Rodríguez Calvo V; Neme R; Pérez-Chada D
PLoS One; 2022; 17(3):e0263679. PubMed ID: 35286328
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania.
Mmbando BP; Segeja MD; Msangeni HA; Sembuche SH; Ishengoma DS; Seth MD; Francis F; Rutta AS; Kamugisha ML; Lemnge MM
Malar J; 2009 Jul; 8():165. PubMed ID: 19615093
[TBL] [Abstract][Full Text] [Related]
18. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
